Cardiac involvement depends on the type of amyloid disease. Systemic amyloidosis occurs in more than 10 per million person-years in the USA. It accounts for 1 in 1000 deaths in the British ...

Cardiac Amyloidosis Cardiac amyloidosis comprises a group of disorders of divergent etiology that is characterized by extracellular myocardial amyloid deposition that leads to cardiac dysfunction ...

The challenges in the current treatment landscape for Alzheimer’s disease (AD) underscore the urgent need for novel therapeutic strategies targeting multiple pathological pathways. Recent studies have ...

Join ACC's Cardiovascular Imaging Member Section on Tuesday, Aug. 5 at 5:30 p.m. ET for a case-based, multi-modality webinar of the contemporary cardiovascular imaging evaluation of cardiac ...

Femtosecond laser arcuate keratotomy (FSAK) performed during cataract surgery can reduce corneal astigmatism, producing stable visual results from the 1-month mark through at least 1 year, an analysis ...

The aggregation of amyloid proteins is responsible for a range of neurodegenerative diseases, and disintegrating these fibrils in the brain is a critical aspect for therapy. Here, we show that an ...

Indications In the EU, AMVUTTRA ® (vutrisiran) is indicated for the treatment of: hereditary transthyretin amyloidosis in adult patients with stage 1 or stage 2 polyneuropathy (hATTR-PN).

Aims The purpose of this study is to elucidate the clinical manifestations and the current treatment status of cytomegalovirus (CMV) endotheliitis via a large case series obtained from a national ...